US 10301304
Selective inhibitor of phosphatidylinositol 3-kinase-gamma
granted A61PA61P1/00A61P1/04
Quick answer
US patent 10301304 (Selective inhibitor of phosphatidylinositol 3-kinase-gamma) held by Vertex Pharmaceuticals Incorporated expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00